NEW YORK, Nov 8 (Reuters) - BNP Paribas (BNPP.PA) is expanding its equity research house Exane in the United States, after the euro zone's biggest lender took it over last year, the bank said on Tuesday.
Michael Rietbrock has joined Exane from Cantor Fitzgerald in October as head of U.S. research, according to BNP.
The move comes as BNP aims to strengthen its equities unit and diversify the lender's business, best known for derivatives.
As part of this strategy, BNP acquired last year a remaining 50% stake in cash equities execution and research house firm Exane, which covers 800 stocks globally.
It's really where we want to grow," Nicolas Marque, head of global equities at BNP Paribas told Reuters.